Lines of Therapy before Autologous Stem Cell Transplant and CAR-T Affect Outcomes in Aggressive Non-Hodgkin's Lymphoma.

Khurana A, Hathcock M, Habermann TM, Saleh AAl, Gandhi S, Truong T, N Bennani N, Paludo J, Villasboas JC, Ansell SM, et al. Lines of Therapy before Autologous Stem Cell Transplant and CAR-T Affect Outcomes in Aggressive Non-Hodgkin's Lymphoma. Am J Hematol. 2021.